Late referral to a nephrologist increases the risk of uremia-related cardiac hypertrophy in patients on hemodialysis

Nephron - Clinical Practice

Volumn 107, Issue 4, 2008, Pages

  Shin, Seok Joon ^a   Kim, Hyung Wook ^a   Chung, Sungjin ^a   Chung, Hyun Wha ^a   Lee, Sang Ju ^a   Kim, Yong Soo ^a   Bang, Byung Kee ^a   Chang, Yoon Sik ^a   Park, Cheol Whee ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Cardiac hypertrophy; Hemodialysis; Inflammation; Late referral

Indexed keywords

C REACTIVE PROTEIN; PARATHYROID HORMONE; SERUM ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLE HYPERTROPHY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITAL ADMISSION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE LINEAR REGRESSION ANALYSIS; NEPHROLOGIST; PATIENT REFERRAL; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; UREMIA;

ADULT; AGE DISTRIBUTION; AGED; CAUSE OF DEATH; COHORT STUDIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; LINEAR MODELS; MALE; MIDDLE AGED; NEPHROLOGY; PROBABILITY; PROGNOSIS; REFERENCE VALUES; REFERRAL AND CONSULTATION; RENAL DIALYSIS; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS; TIME FACTORS; UREMIA;

EID: 38049024573     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000110034     Document Type: Article

References (37)

1. US Renal Data System: USRDS 2002 Annual Data Report, Bethesda, National Institutes of Health. Bethesda, National Institutes of Diabetes and Digestive and Kidney Disease, 2002.
2. McMurray JV, McDonagh TA, Davie AP, et al: Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure? Eur Heart J 1998;19:842-846.
3. Zoccali C, Benedetto FC, Mallamaci F, et al: Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients. J Am Soc Nephrol 2004;15:1029-1037.
4. Foley RN, Parfrey PS, Harnett JD, et al: The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 1995;5:2024-2031.
5. Parfrey PS, Foley RN, Harnett JD, et al: Outcome and risk factors for left ventricular disorders in chronic uremia. Nephrol Dial Transplant 1996;11:1277-1285.
6. Foley RN, Parfrey PS, Kent GM, et al: Longterm evolution of cardiomyopathy in dialysis patients. Kidney Int 1998;54:1720-1725.
7. Zoccali C, Benedetto FA, Mallamaci B, et al: Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol 2001;12:2768-2774.
8. London GM, Pannier B, Guerin AP, et al: Alterations of the left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 2001;12:2759-2767.
9. Levin A, Singer J, Thompson CR, Ross H, Lewis M: Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 1996;27:347-354.
10. Foley RN, Parfrey PS, Harnett JD, et al: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1999;47:186-192.
11. Kinchen KS, Sadler J, Fink N, et al: The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med 2002;137:479-486.
12. Arora P, Obrador GT, Ruthazer R, et al: Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center. J Am Soc Nephrol 1999;10:1281-1286.
13. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-733.
14. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-658.
15. Winkelmayer WC, Owen WF Jr, Levin R, Avorn JA: A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol 2003;14:486-492.
16. Shan DJ, DeMore A, Kisslo J, Weyman A: Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echo measurement. Circulation 1978;58:1072-1083.
17. Devereux RB, Koren MJ, Simone G, Okin PM, Kligfield P: Methods of detection of left ventricular hypertrophy: application to hypertensive heart disease. Eur Heart J 1993;14:SD8-SD15.
18. de Simone G, Devereux RB, Daniel SR, et al: Effect of growth on variability of left ventricular mass: assessment of allometrix signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995;25:1056-1062.
19. Stack AG: Impact of timing of nephrology referral and pre-ESRDA care on mortality risk among new ESRD patients in the United States. Am J Kidney Dis 2003;41:310-318.
20. Jungers P, Zingraff J, Page B, et al: Detrimental effects of late referral in patients with chronic renal failure: a case-control study. Kidney Int Suppl 1993;41:S170-S173.
21. Roubicek C, Brunet P, Huiart L, et al: Timing of nephrology referral: influence on mortality and morbidity. Am J Kidney Dis 2000;36:35-41.
22. Jungers P, Massy ZA, Nguyen-Khoa T, et al: Long duration of pre-hemodialysis nephrological care is associated with improved long-term survival of dialysis patients. Nephrol Dial Transplant 2001;16:2357-2364.
23. Zoccali C, Benedetto FA, Mallamaci F, et al: Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int 2004;65:1492-1498.
24. Stenvinkel P, Heimburger O, Paultre F, et al: Strong associations between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney Int 1999;55:1899-1911.
25. Bergstrom J, Lindholm B: Malnutrition, cardiac disease and mortality: an integrated point of view. Am J Kidney Dis 1998;32:834-841.
26. Park CW, Oh YS, Shin YS, et al: Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 1999;33:73-81.
27. Park CW, Shin YS, Kim CM, et al: Increased C-reactive protein following hemodialysis predicts cardiac hypertrophy in chronic hemodialysis patients. Am J Kidney Dis 2002;40:1230-1239.
28. Loughrey CM, Young IS, Lightbody JH, et al: Oxidative stress in hemodialysis. QJM 1994;87:679-683.
29. Miyata T, Wada Y, Cai Z, et al: Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 1997;51:1170-1181.
30. Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW: Alterations in nonenzymatic biochemistry in uremia: origin and significance of 'carbonyl stress' in long-term uremic complication. Kidney Int 1999;55:389-399.
31. Oberg BP, McMenamin E, Lucas FL, et al: Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 2004;65:1009-1016.
32. Foley RN: Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure. Semin Dial 2003;16:111-117.
33. London GM, Fabiani F, Marchais SJ, et al: Uremic cardiomyopathy: an inadequate left ventricular hypertrophy. Kidney Int 1987;31:973-980.
34. Astor BC, Eustace JA, Powe NR, et al: Timing of nephrologist referral and arteriovenous access use: the CHOICE Study. Am J Kidney Dis 2001;38:494-501.
35. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W: Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int 1999;55:1081-1090.
36. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB: Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 1997;127:275-280.
37. Gonçalves EAP, Andreoli MC, Watanabe R, et al: Effect of temporary catheter and late referral on hospitalization and mortality during the first year of hemodialysis treatment. Artif Org 2004;28:1043-1049.